KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $288.3 million.

  • Idexx Laboratories' Cash & Current Investments fell 32.55% to $208.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $825.0 million, marking a year-over-year decrease of 47.17%. This contributed to the annual value of $288.3 million for FY2024, which is 36.50% down from last year.
  • As of FY2024, Idexx Laboratories' Cash & Current Investments stood at $288.3 million, which was down 36.50% from $453.9 million recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Cash & Current Investments registered a high of $453.9 million during FY2023, and its lowest value of $112.5 million during FY2022.
  • Over the past 3 years, Idexx Laboratories' median Cash & Current Investments value was $288.3 million (recorded in 2024), while the average stood at $284.9 million.
  • In the last 5 years, Idexx Laboratories' Cash & Current Investments soared by 325.05% in 2020 and then crashed by 62.37% in 2021.
  • Yearly analysis of 5 years shows Idexx Laboratories' Cash & Current Investments stood at $383.9 million in 2020, then plummeted by 62.37% to $144.5 million in 2021, then decreased by 22.09% to $112.5 million in 2022, then soared by 303.33% to $453.9 million in 2023, then tumbled by 36.50% to $288.3 million in 2024.